Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Keratinocytes show more TGF-β system activity and collagen production as they age, which might affect wound scarring.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Biotin supplements are unnecessary for most people but may help with certain conditions like biotin deficiency, brittle nails, and some hair loss.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Eating raw cheonggukjang improves scalp hair in middle-aged women.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.